Sign In
Buy SEER
$1.86
-0.0100 (-0.535%)
At Close: Jun 03, 2026
Seer to Present at the Morgan Stanley Global Healthcare Conference
04:05pm, Thursday, 02'nd Sep 2021
REDWOOD CITY, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will be partic
Seer, Inc.'s (SEER) CEO Omid Farokhzad on Q2 2021 Results - Earnings Call Transcript
11:18pm, Thursday, 12'th Aug 2021
Seer, Inc.'s (SEER) CEO Omid Farokhzad on Q2 2021 Results - Earnings Call Transcript
Seer Reports Second Quarter 2021 Financial Results
04:06pm, Thursday, 12'th Aug 2021
Expanded installed base and booked initial revenue for Proteograph Product Suite Expanded installed base and booked initial revenue for Proteograph Product Suite
Earnings Previews: Airbnb, ContextLogic, Disney, Seer, SoFi
11:57am, Wednesday, 11'th Aug 2021
Of a dozen firms that reported earnings before markets opened on Wednesday, eight beat estimates and four missed.
Seer to Report Second Quarter Financial Results on August 12, 2021
04:05pm, Tuesday, 13'th Jul 2021
REDWOOD CITY, Calif., July 13, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report fina
Biodesix Announces Presentation on Novel Proteomic Techniques in Partnership with Seer
04:01pm, Thursday, 17'th Jun 2021
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company, today announced in partnership with Seer, Inc. (NASDAQ: SEE
Seer, Inc. (SEER) CEO Omid Farokhzad on Q1 2021 Results - Earnings Call Transcript
08:10pm, Monday, 10'th May 2021
Seer, Inc. (SEER) CEO Omid Farokhzad on Q1 2021 Results - Earnings Call Transcript
Seer Reports First Quarter 2021 Financial Results
04:05pm, Monday, 10'th May 2021
Second Phase of Commercialization Advances with the Addition of Multiple Limited Release Customers
Seer to Present at the BofA Securities 2021 Healthcare Conference
04:05pm, Tuesday, 04'th May 2021
REDWOOD CITY, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will be particip
Seer's (SEER) CEO Omid Farokhzad on Q4 and Full Year 2020 Results - Earnings Call Transcript
11:22pm, Monday, 29'th Mar 2021
Seer's (SEER) CEO Omid Farokhzad on Q4 and Full Year 2020 Results - Earnings Call Transcript
Added Salk Institute as collaboration customer and SCIEX as new commercial partner Added Salk Institute as collaboration customer and SCIEX as new commercial partner
Olink Holding Pursues $300 Million U.S. IPO Effort
03:42pm, Monday, 22'nd Mar 2021
Olink Holding AB has filed to raise $300 million in a U.S. IPO.
Seer to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021
08:05am, Monday, 01'st Mar 2021
REDWOOD CITY, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report fi
Top 4th-Quarter Buys of Lee Ainslie's Maverick Capital
06:06pm, Wednesday, 24'th Feb 2021
Lee Ainslie (Trades, Portfolio), the founder and CEO of Maverick Capital, recently disclosed the firm's portfolio changes for the fourth quarter of 2020, which ended on Dec. 31.
Seer Announces Closing of Public Offering of Common Stock
04:05pm, Monday, 01'st Feb 2021
REDWOOD CITY, Calif. , Feb. 01, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company commercializing a disruptive new platform for proteomics, today announced the closing of an underwritten pu
